Last updated on August 2019

A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment


Find a site near you

Start Over

SIH Research, LLC /ID# 163081

Kissimmee, FL United States
  Connect »

Alliance Medical Research /ID# 163834

Lighthouse Point, FL United States
  Connect »

ITB Research /ID# 161278

Miami, FL United States
  Connect »

Advanced Research Institute /ID# 161973

New Port Richey, FL United States
  Connect »

IMIC Inc. /ID# 154944

Palmetto Bay, FL United States
  Connect »

Delricht Research /ID# 206567

New Orleans, LA United States
  Connect »

NY Scientific /ID# 158272

Brooklyn, NY United States
  Connect »

Tri-State Endoscopy /ID# 154939

Cincinnati, OH United States
  Connect »

Hightower Clinical /ID# 211992

Oklahoma City, OK United States
  Connect »

Gastro One /ID# 154757

Germantown, TN United States
  Connect »

Sagact Pllc /Id# 168772

San Antonio, TX United States
  Connect »

Cemic /Id# 168082

Buenos Aires, Argentina
  Connect »

Hospital Britanico de Buenos /ID# 168081

Ciudad Autonomade Buenos Aires, Argentina
  Connect »

Hopital Nord /ID# 162550

Saint Priest En Jarez, France
  Connect »

Mediclinic Milnerton /ID# 171172

CAPE TOWN,Milnerton, South Africa
  Connect »